|
|
|
R E S O L U T I O N
|
|
|
WHEREAS, The University of Texas Medical Branch has made |
|
important strides toward conquering the Ebola virus by developing a |
|
promising vaccine; and |
|
WHEREAS, Scheduled for human trials in the summer of 2015, |
|
the vaccine is designed to treat the strain of Ebola that has killed |
|
more than 10,000 people in West Africa since December 2013; it is a |
|
modified version of a vaccine developed in the previous decade, and |
|
it is one of only two being studied in humans; and |
|
WHEREAS, The medical branch developed the fast-acting, |
|
single-dose vaccine in an interdisciplinary partnership with |
|
Profectus BioSciences; researchers conducted nonhuman primate |
|
testing in the Galveston National Laboratory, the only fully |
|
operational Biosafety Level 4 laboratory on an academic campus in |
|
the United States; in April 2015, the results were published in the |
|
scientific journal Nature; the research is supported by the |
|
National Institutes of Health and the UTMB Department of |
|
Microbiology and Immunology; and |
|
WHEREAS, The findings at UTMB may pave the way for the |
|
manufacture of a safer, single-dose, high-efficiency vaccine to |
|
combat Ebola outbreaks, potentially saving an untold number of |
|
lives; now, therefore, be it |
|
RESOLVED, That the House of Representatives of the 84th Texas |
|
Legislature hereby honor The University of Texas Medical Branch for |
|
its development of a promising Ebola vaccine and extend to all those |
|
associated with this research sincere best wishes for continued |
|
success in their important work; and, be it further |
|
RESOLVED, That an official copy of this resolution be |
|
prepared for UTMB as an expression of high regard by the Texas House |
|
of Representatives. |
|
|
Faircloth |
|
|
|
______________________________ |
|
Speaker of the House |
|
|
I certify that H.R. No. 2464 was adopted by the House on May |
|
21, 2015, by a non-record vote. |
|
|
|
______________________________ |
|
Chief Clerk of the House |
|